We are excited to announce that there's new
@uk_biobank
data analyzed by Nightingale Health available for researchers, including biomarker results from an additional 200,000 blood samples.
Learn more:
To celebrate the 200th birth anniversary of Florence Nightingale, we thought of sharing 200 stories from her life starting this week hoping she inspires others as she has inspired us at Nightingale.
More 👉
#CelebratingFlorence
#200NightingaleStories
Nightingale is taking part in
@theinklusiiv
, a campaign raising awareness to make work life more diverse. You can read more about the campaign (in Finnish) from Inklusiiv’s webpage:
#diversity
#work
We have successfully completed a funding round with EUR 8.8 million of new capital from a group of leading Finnish private investors. One of the investors, Leena Niemistö, has been appointed as a member of the Board.
Read more:
Prof Sir Rory Collins
#UKBiobank
demonstrated what a busy, productive year we've had: primary care date on 230K, imaging data on 48K, metabolomics complete on 127K, Whole Genome Sequencing complete on 150K!
#Thankyou
to all staff, collaborators & participants
#UKBCONf20
A recent study with 500,000 blood samples from three national biobanks shows that, in many cases, metabolic data outperforms genetic data in risk prediction.
The world's largest study combining blood biomarkers and genetics by the Nightingale Health Biobank Collaborative Group
#NSAwards
🇫🇮🇮🇸🇩🇰🇸🇪🇳🇴 Next up China and the Global Startup Awards! Congrats to all the winners, Nightingale excited to represent Nordics in the Health Tech Category 🤓
#Nordicmade
Introducing My Nightingale –– the world’s most comprehensive health data –– now in your pocket. This is our first step in bringing preventive health for 8 billion people.
✨⚡️Take a look 👉
#Health
#data
#prevention
#HealthForAll
Meet the Slush 2018 speakers! Founders and early employees of tech companies who have created, built and scaled the most critical functions and teams – be that technology, product, marketing, talent or other cornerstones of the company.
Today we released further landmark evidence to showcase the ability of our technology to predict hundreds of diseases from a single blood sample.
Pre-print:
Free webtool:
Press release:
Nightingale to roll-out novel preventative solution for COVID-19 enabling safe returns to work post lockdowns – Research shows blood test predicts severity of COVID-19 before contracting the virus
BIG NEWS! We began service of My Nightingale, our advanced blood-testing for consumers, today in Helsinki. As a part of it, we also opened doors at Nightingale Nest, our first blood-drawing location.
Full story 👉
#mynightingale
#nightingalenest
Nightingale § our CEO
@teemusuna
have been nominated by
@NSAwards
as
#Startup
of the Year, Best HealthTech Startup § Founder of the Year. Congratulations to all the finalists! If you'd like to see us at the final, please
#VOTE
for us here:
#NSAwards
📣 We have reached a significant milestone by completing the analysis of all 500,000
@uk_biobank
samples. This accomplishment creates the world's largest blood biomarker database, advancing research and prevention of chronic diseases.
Renowned for its vast and continuously
”In AI & data science, choosing a good problem to solve is the first step. Then, the chosen tools need to match the problem” Nightingale’s Senior Data Scienctist
@ouzor
shares his insights on Artificial Intelligence and machine learning.
#AI
#datascience
#health
#nightingaleflock
”Our aim is to get
#European
innovations moving. It is exceptionally wonderful to support a technology that enables preventing diseases. Let’s keep the world healthy!”
@alexstubb
@EIB
#EFSI
#InvestEU
We have entered into a strategic partnership agreement with Terveystalo. Based on the cooperation, a new subscription service will be built, which can be used through the Terveystalo application. Read more:
”Our story began not in a garage but a big vision built in a small cafe - with our blood test, we aim to enable preventive healthcare”
@teemusuna
#slush18
#showcase
#bloodtest
#datadriven
p.s. Check out our first consumer service at the Aava x Nightingale booth!
We are honored to provide
#metabolics
data for one of the biggest and most ambitious
#Health
projects in the world and support
@uk_biobank
in this massive endeavor
Through blood tests 💉 body scans 🏥 and medical records 📋 500,000 healthy people left science a gift.
Now, the entire genetic code of those volunteers will be read, unlocking new potential for
@uk_biobank
to improve health 🧬
✍️ Sara Marshall
Our CSO
@jcbarret
led a Covid research team before joining Nightingale. Now, he’s on a mission to bring lifelong health within everyone's reach. Get to know Jeff:
“The main message of this study is that being physically active is associated with a lower risk of
#heartdisease
, even if you have a high
#genetic
risk.” Exciting results with implications for
#lifestyle
intervention strategies for
#patients
-
Nightingale has entered into a service agreement with Mitsui & Co.’s fully owned subsidiary (Welltus Inc.) to sell health and well-being services in the Japanese market.
Read more:
JUST IN: Yrjö Närhinen joins Nightingale as an investor & strategic advisor. Närhinen, best known for his role as the former CEO of Terveystalo––the largest private healthcare service in Finland, will help accelerate our international growth.
More 👉
Nightingale introduces the combination of its proprietary blood test and genomics: acquires Finnish genetic testing company Negen and launches an international centre of excellence for genomic data analysis. Read more:
#throwback
to Nov'19 when we launched My Nightingale, our consumer blood-testing service
@SlushHQ
. Tomorrow, January 30, we take another giant leap as we open doors for customers at Nightingale Nest Helsinki––our first blood-drawing centre. More exciting news coming. Stay tuned!
#BigNews
Nightingale has appointed Swedbank AB as the lead financial advisor to explore different financing options, including possibilities of an Initial Public Offering by listing the Company’s shares on Nasdaq Helsinki First North.
Details:
@cecilejanssens
@michelnivard
Biggest ever consistent MRI imaging protocol happening in the works now on
@uk_biobank
(torso, brain, heart); full metabolomics (from
@NgaleHealth
) ; comprehensive primary care records ; regular hospital episode statistics -
@uk_biobank
is waaay more than genetics :)
Nightingale's Scientific Director
@PeterWyrtz
with Prof Naomi Allen (
@uk_biobank
Senior Epidemiologist) and Prof Sir Rory Collins (UK Biobank's Principal Investigator) at the UK Biobank Scientific Conference 2018.
#ukbconf18
Nightingale on solminut strategisen yhteistyösopimuksen Terveystalon kanssa. Yhteistyön pohjalta rakennetaan uutta tilauspohjaista palvelua, jota voi käyttää Terveystalon sovelluksen kautta. Lue lisää: